Skip to main content

Table 3 Results of Begg’s test and Egger’s test

From: Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m2 conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis

Outcome

PBegg’s test

PEgger’s test

Progression-free survival

0.902

0.376

Overall survival

0.917

0.990

Best treatment response

0.118

0.139

Neutrophil engraftment

1.000

0.994

Platelet engraftment

1.000

0.400

Infection

0.133

0.119

Mucositis

0.368

0.202

Hepatic toxicity

0.260

0.164

Gastrointestinal toxicity

0.452

0.462